Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model.

PURPOSE To evaluate quantitative functional ultrasonography (US) in a murine gel model by using microbubble destruction kinetics to determine whether parametric indices provided with US could help assess angiogenesis. MATERIALS AND METHODS Institutional Animal Subjects Committee approved experiments and procedures. In 36 normal mice, two 0.4-mL gel implants were placed subcutaneously on either side of spine. One implant contained 0.5, 1.0, or 1.5 microg human basic fibroblast growth factor (bFGF) per milliliter of gel. Functional US quantitative analysis of angiogenesis with microbubble contrast agent was performed on days 3, 6, 9, and 12; histologic data were collected. Time-intensity curve of implant was fitted to mathematic decay model to calculate fractional blood volume and fraction of blood replaced per unit of time. Microvascular density (MVD) and percentage of microvascular area (MVA) were measured after anti-CD31 staining. Spearman rank order correlation was used in analyses. RESULTS bFGF-containing implants induced MVD of eight, 35, 42, and 42 vessels per square millimeter on days 3, 6, 9, and 12, respectively; in controls, MVD was four vessels/mm2 (P<.05 on days 6, 9, and 12). bFGF-containing implants induced percentage MVA of 2%, 5%, 20%, and 27%, respectively; in controls, it was 0.5% (P<.05). Maximum enhancement was significantly increased in bFGF implants (23.3 gray level+/-14.1 [standard deviation]) compared with controls (11.0+/-5.5, P<.001). Implants containing bFGF showed poor correlations between fractional blood volume and MVD (r2=0.42) or percentage MVA (r2=0.51) at US. There was no correlation between microbubble velocity and MVD (r2<0.05) or percentage MVA (r2<0.13). CONCLUSION Functional US perfusion parameters do not correlate with current histologic indices for quantifying angiogenesis. MVD, as a histologic quantitative measurement of angiogenesis, may not be an appropriate standard for contrast-enhanced imaging that relies on perfused neovessels.

[1]  S. Delorme,et al.  Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology. , 2001, Ultrasound in medicine & biology.

[2]  R. Kerbel,et al.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.

[3]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[4]  H. Przuntek,et al.  Contrast Burst Depletion Imaging (CODIM): A New Imaging Procedure and Analysis Method for Semiquantitative Ultrasonic Perfusion Imaging , 2003, Stroke.

[5]  S. Kaul,et al.  Quantification of renal blood flow with contrast-enhanced ultrasound. , 2001, Journal of the American College of Cardiology.

[6]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[7]  Y. Kono,et al.  Validation of ultrasound contrast destruction imaging for flow quantification. , 2003, Ultrasound in medicine & biology.

[8]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[9]  L. Ellis,et al.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.

[10]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[11]  D. Noh,et al.  Identification of Angiogenesis in Primary Breast Carcinoma According to the Image Analysis , 2002, Breast Cancer Research and Treatment.

[12]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[13]  G. Bartsch,et al.  Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. , 2001, Anticancer research.

[14]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[15]  H. Becher,et al.  Feasibility of the flash-replenishment concept in renal tissue: which parameters affect the assessment of the contrast replenishment? , 2001, Ultrasound in medicine & biology.

[16]  Olivier Lucidarme,et al.  Angiogenesis model for ultrasound contrast research: exploratory study. , 2004, Academic radiology.

[17]  J. Bartko,et al.  On Various Intraclass Correlation Reliability Coefficients , 1976 .

[18]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[19]  Plunkett Ml,et al.  An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. , 1990 .

[20]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[21]  N. de Jong,et al.  A new ultrasound contrast imaging approach based on the combination of multiple imaging pulses and a separate release burst , 2001, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[22]  G. Seidel,et al.  Evaluation of blood flow in the cerebral microcirculation: analysis of the refill kinetics during ultrasound contrast agent infusion. , 2001, Ultrasound in medicine & biology.

[23]  C. Verschraegen,et al.  Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. , 1998, The New England journal of medicine.

[24]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[25]  Julie Morris,et al.  Assessment of Vascularity in Histological Sections: Effects of Methodology and Value as an Index of Angiogenesis in Breast Tumours , 1998, The Histochemical Journal.

[26]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[27]  Susannah H Bloch,et al.  Contrast-assisted Destruction-replenishment Ultrasound for the Assessment of Tumor Microvasculature in a Rat Model , 2002, Technology in cancer research & treatment.

[28]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[29]  E. Kohn,et al.  A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  G. Brewer,et al.  Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. , 2002, Transactions of the American Ophthalmological Society.

[31]  P. Hauff,et al.  Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. , 2001, Ultrasound in medicine & biology.

[32]  D. Sahn,et al.  Ultrasound-mediated destruction of contrast agents. Effect of ultrasound intensity, exposure, and frequency. , 1997, Investigative radiology.

[33]  Adam P Dicker,et al.  Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. , 2002, Ultrasound in medicine & biology.

[34]  Roy S Herbst,et al.  Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. , 2002, Seminars in oncology.

[35]  S. Libutti,et al.  Monitoring responses to antiangiogenic agents using noninvasive imaging tests. , 1999, The cancer journal from Scientific American.

[36]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[37]  M. Nguyen,et al.  Regression of Metastatic Breast Cancer in a Patient Treated with the Anti-Angiogenic Drug Tnp-470 , 1999, Tumori.

[38]  B. Zetter,et al.  Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. , 2002, Radiology.

[39]  S. Steinberg,et al.  A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  Y. Chung,et al.  Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. , 1995, British Journal of Cancer.